- Home
- BRCB vs SIGA Comparison
BRCB vs SIGA Comparison
Compare BRCB & SIGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BRCB | SIGA |
|---|---|---|
| Founded | 2008 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 388.9M | 462.6M |
| IPO Year | 2025 | 1997 |
Fundamental Metrics
Financial Performance| Metric | BRCB | SIGA |
|---|---|---|
| Price | $21.95 | $6.11 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $28.40 | N/A |
| AVG Volume (30 Days) | ★ 521.3K | 334.4K |
| Earning Date | 02-08-2026 | 11-06-2025 |
| Dividend Yield | N/A | ★ 9.82% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.03 |
| Revenue | ★ $189,494,000.00 | $172,249,641.00 |
| Revenue This Year | $26.92 | N/A |
| Revenue Next Year | $27.11 | $132.36 |
| P/E Ratio | ★ N/A | $5.93 |
| Revenue Growth | ★ 42.30 | N/A |
| 52 Week Low | $19.32 | $4.95 |
| 52 Week High | $30.40 | $9.62 |
Technical Indicators
Market Signals| Indicator | BRCB | SIGA |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 38.63 |
| Support Level | N/A | $6.20 |
| Resistance Level | N/A | $6.45 |
| Average True Range (ATR) | 0.00 | 0.15 |
| MACD | 0.00 | 0.03 |
| Stochastic Oscillator | 0.00 | 5.48 |
Price Performance
Historical ComparisonAbout BRCB Black Rock Coffee Bar Inc.
Black Rock Coffee Bar Inc is a high-growth operator of guest-centric, drive-thru coffee bars offering premium caffeinated beverages and an elevated in-store experience crafted by its engaging baristas. It offers a broad range of premium coffee beverages, from its deliciously refreshing Nitro Cold Brew to its unapologetically indulgent Caramel Blondie. The company also offer competitively priced, premium classics, including the Americano and customizable Lattes, providing a high perceived value offering to its guests.
About SIGA SIGA Technologies Inc.
SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.